Maple Syrup Urine Disease
📧 Sign up to get email alerts when something new happens for Maple Syrup Urine Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Evaluation of the Express Plus Range [NA]
A completed clinical trial evaluated Vitaflo's Express Plus Range for multiple metabolic disorders including phenylketonuria, homocystinuria…
-
EMA approval · 2025-09-30EMA Authorised: Maapliv (glycine,L-alanine,L-arginine,L-aspartic acid,L-cysteine hydrochloride monohydrate,L-histidine,L-methionine,L-phenylalanine,L-proline,L-serine,L-threonine,L-tryptophan,L-tyrosine,L-glutamic acid,L-lysine monohydrate,taurine) — Recordati Rare Diseases
EMA authorised Maapliv for Maple Syrup Urine Disease, an amino-acid based product developed for an orphan indication by Recordati Rare Disea…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Early Check: Expanded Screening in Newborns
An update on an ongoing clinical trial (NCT03655223) evaluating expanded newborn screening under the Early Check program, with enrollment by…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: MyRareDiet A Novel Diet Tracking Tool [NA]
This clinical trial update outlines MyRareDiet, a novel diet-tracking tool being studied for urea cycle disorders and related organic acidem…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Liquid Valine and Isoleucine in Maple Syrup Urine Disease [NA]
ClinicalTrials.gov lists a study evaluating liquid valine and isoleucine for Maple Syrup Urine Disease, with the trial status not yet recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)
This clinical trial update reports on neurocognitive outcomes and quality of life in adults with Maple Syrup Urine Disease, noting that the …
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Phenylbutyrate Therapy for Maple Syrup Urine Disease [Phase 2, Phase 3]
Phase 2 and Phase 3 trial update for phenylbutyrate therapy in Maple Syrup Urine Disease with completed status and posted results.